ID   GLYR1_MOUSE             Reviewed;         546 AA.
AC   Q922P9; Q3TX02; Q9CYQ1;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   07-APR-2021, entry version 148.
DE   RecName: Full=Putative oxidoreductase GLYR1;
DE            EC=1.-.-.-;
DE   AltName: Full=Glyoxylate reductase 1 homolog;
DE   AltName: Full=Nuclear protein NP60;
GN   Name=Glyr1; Synonyms=Np60;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Bone marrow, and Embryo;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=16452087; DOI=10.1074/mcp.t500041-mcp200;
RA   Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R., Burlingame A.L.;
RT   "Comprehensive identification of phosphorylation sites in postsynaptic
RT   density preparations.";
RL   Mol. Cell. Proteomics 5:914-922(2006).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [5]
RP   FUNCTION.
RX   PubMed=29759984; DOI=10.1101/gad.313973.118;
RA   Fei J., Ishii H., Hoeksema M.A., Meitinger F., Kassavetis G.A., Glass C.K.,
RA   Ren B., Kadonaga J.T.;
RT   "NDF, a nucleosome-destabilizing factor that facilitates transcription
RT   through nucleosomes.";
RL   Genes Dev. 32:682-694(2018).
CC   -!- FUNCTION: Nucleosome-destabilizing factor that is recruited to genes
CC       during transcriptional activation (PubMed:29759984). Facilitates Pol II
CC       transcription through nucleosomes (By similarity). Binds DNA (in vitro)
CC       (By similarity). Recognizes and binds trimethylated 'Lys-36' of histone
CC       H3 (H3K36me3) (PubMed:29759984). Promotes KDM1B demethylase activity
CC       (By similarity). Stimulates the acetylation of 'Lys-56' of nucleosomal
CC       histone H3 (H3K56ac) by EP300 (By similarity). Regulates p38 MAP kinase
CC       activity by mediating stress activation of p38alpha/MAPK14 and
CC       specifically regulating MAPK14 signaling (By similarity). Indirectly
CC       promotes phosphorylation of MAPK14 and activation of ATF2 (By
CC       similarity). The phosphorylation of MAPK14 requires upstream activity
CC       of MAP2K4 and MAP2K6 (By similarity). Putative oxidoreductase (By
CC       similarity). {ECO:0000250|UniProtKB:Q49A26,
CC       ECO:0000269|PubMed:29759984}.
CC   -!- SUBUNIT: Interacts with MAPK14. Interacts with KDM1B at nucleosomes;
CC       this interaction stimulates H3K4me1 and H3K4me2 demethylation. Binds to
CC       mononucleosomes. {ECO:0000250|UniProtKB:Q49A26}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q49A26}.
CC       Chromosome {ECO:0000250|UniProtKB:Q49A26}.
CC   -!- DOMAIN: The A.T hook DNA-binding domain is required for the interaction
CC       with MAPK14. {ECO:0000250|UniProtKB:Q49A26}.
CC   -!- DOMAIN: The PWWP domain probably mediates the binding to H3K36me3.
CC       {ECO:0000250|UniProtKB:Q49A26}.
CC   -!- MISCELLANEOUS: The conserved NAD-binding sites and sequence similarity
CC       to plant dehydrogenases suggest that this protein may have
CC       oxidoreductase activity. {ECO:0000250|UniProtKB:Q49A26}.
CC   -!- SIMILARITY: Belongs to the HIBADH-related family. NP60 subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK014456; BAB29363.1; -; mRNA.
DR   EMBL; AK150349; BAE29486.1; -; mRNA.
DR   EMBL; AK152887; BAE31570.1; -; mRNA.
DR   EMBL; AK159476; BAE35114.1; -; mRNA.
DR   EMBL; BC006893; AAH06893.1; -; mRNA.
DR   CCDS; CCDS27930.1; -.
DR   RefSeq; NP_082996.2; NM_028720.2.
DR   SMR; Q922P9; -.
DR   BioGRID; 216431; 2.
DR   IntAct; Q922P9; 4.
DR   MINT; Q922P9; -.
DR   STRING; 10090.ENSMUSP00000111510; -.
DR   iPTMnet; Q922P9; -.
DR   PhosphoSitePlus; Q922P9; -.
DR   EPD; Q922P9; -.
DR   MaxQB; Q922P9; -.
DR   PaxDb; Q922P9; -.
DR   PeptideAtlas; Q922P9; -.
DR   PRIDE; Q922P9; -.
DR   ProteomicsDB; 263378; -.
DR   Antibodypedia; 24437; 105 antibodies.
DR   Ensembl; ENSMUST00000023189; ENSMUSP00000023189; ENSMUSG00000022536.
DR   GeneID; 74022; -.
DR   KEGG; mmu:74022; -.
DR   UCSC; uc007ybm.1; mouse.
DR   CTD; 84656; -.
DR   MGI; MGI:1921272; Glyr1.
DR   eggNOG; KOG0409; Eukaryota.
DR   eggNOG; KOG1904; Eukaryota.
DR   GeneTree; ENSGT00940000156435; -.
DR   InParanoid; Q922P9; -.
DR   BioGRID-ORCS; 74022; 5 hits in 55 CRISPR screens.
DR   ChiTaRS; Glyr1; mouse.
DR   PRO; PR:Q922P9; -.
DR   Proteomes; UP000000589; Chromosome 16.
DR   RNAct; Q922P9; protein.
DR   Bgee; ENSMUSG00000022536; Expressed in ear vesicle and 296 other tissues.
DR   ExpressionAtlas; Q922P9; baseline and differential.
DR   Genevisible; Q922P9; MM.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0000786; C:nucleosome; ISS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0042393; F:histone binding; ISS:UniProtKB.
DR   GO; GO:0035064; F:methylated histone binding; ISS:UniProtKB.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0050661; F:NADP binding; IEA:InterPro.
DR   GO; GO:0031491; F:nucleosome binding; ISO:MGI.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR   GO; GO:0035066; P:positive regulation of histone acetylation; ISO:MGI.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:MGI.
DR   CDD; cd05836; N_Pac_NP60; 1.
DR   Gene3D; 1.10.1040.10; -; 1.
DR   InterPro; IPR008927; 6-PGluconate_DH-like_C_sf.
DR   InterPro; IPR013328; 6PGD_dom2.
DR   InterPro; IPR006115; 6PGDH_NADP-bd.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR029154; NADP-bd.
DR   InterPro; IPR035501; NP60_PWWP.
DR   InterPro; IPR000313; PWWP_dom.
DR   Pfam; PF14833; NAD_binding_11; 1.
DR   Pfam; PF03446; NAD_binding_2; 1.
DR   Pfam; PF00855; PWWP; 1.
DR   SMART; SM00293; PWWP; 1.
DR   SUPFAM; SSF48179; SSF48179; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS50812; PWWP; 1.
PE   1: Evidence at protein level;
KW   Chromosome; DNA-binding; Isopeptide bond; NAD; Nucleus; Oxidoreductase;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN           1..546
FT                   /note="Putative oxidoreductase GLYR1"
FT                   /id="PRO_0000312122"
FT   DOMAIN          8..66
FT                   /note="PWWP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00162"
FT   DNA_BIND        167..179
FT                   /note="A.T hook"
FT                   /evidence="ECO:0000305"
FT   NP_BIND         270..284
FT                   /note="NAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   REGION          213..216
FT                   /note="Interaction with histone H3"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   REGION          215..224
FT                   /note="Interaction with KDM1B"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   BINDING         355
FT                   /note="NAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   BINDING         498
FT                   /note="NAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   SITE            216
FT                   /note="Required to promote KDM1B demethylase activity
FT                   toward histone H3K4me1 and H3K4me2"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   MOD_RES         130
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   MOD_RES         166
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   MOD_RES         533
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   CROSSLNK        135
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   CROSSLNK        175
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   CROSSLNK        178
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   CROSSLNK        200
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   CROSSLNK        210
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   CROSSLNK        226
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   CROSSLNK        236
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   CROSSLNK        239
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   CROSSLNK        268
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   CROSSLNK        301
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q49A26"
FT   CONFLICT        50..51
FT                   /note="ED -> KN (in Ref. 1; BAB29363)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        109..110
FT                   /note="NR -> DW (in Ref. 1; BAB29363)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        296
FT                   /note="N -> S (in Ref. 1; BAE35114)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        535
FT                   /note="N -> S (in Ref. 1; BAE35114)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   546 AA;  59716 MW;  F5D2090DE1F64723 CRC64;
     MAAVSLRLGD LVWGKLGRYP PWPGKIVNPP KDLKKPRGKK CFFVKFFGTE DHAWIKVEQL
     KPYHAHKEEM IKINKGKRFQ QAVDAVEEFL RRAKGKDQTS SHTSADDKNR RNSSEERSRP
     NSGDEKRKLS LSEGKVKKNM GEGKKRVTSG SADRGSKCLK RAQEQSPRKR GRPPKDEKDL
     TIPESSTVKG MMAGPMAAFK WQPTATEPVK DADPHFHHFL LSQTEKPAVC YQAITKKLKI
     CEEETGSTSI QAADSTAVNG SITPTDKKIG FLGLGLMGSG IVSNLLKMGH TVTVWNRTAE
     KEGARLGRTP AEVVSTCDIT FACVSDPKAA KDLVLGPSGV LQGIRPGKCY VDMSTVDADT
     VTELAQVIVS RGGRFLEAPV SGNQQLSNDG MLVILAAGDR GLYEDCSSCF QAMGKTSFFL
     GEVGNAAKMM LIVNMVQGSF MATIAEGLTL AQVTGQSQQT LLDILNQGQL ASIFLDQKCQ
     NILQGNFKPD FYLKYIQKDL RLAIALGDAV NHPTPMAAAA NEVYKRAKAL DQSDNDMSAV
     YRAYIH
//
